Skip to main navigation Skip to search Skip to main content

Maternal whole blood viscosity in pregnancy hypertension

  • H. A. Zondervan*
  • , J. Oosting
  • , M. E. Smorenberg-Schoorl
  • , P. E. Trejfers
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Hemoconcentration is prominent in preeclampsia. Concomitant changes in the flow properties of maternal blood, i.e. In whole blood viscosity (WBV), might be related to the occurrence of fetal or maternal complications. To test this hypothesis, WBV was estimated in 228 pregnancies. Patients were assigned to one of four groups according to maximum diastolic blood pressure. Significantly higher WBV values were found in the more hypertensive groups throughout pregnancy. WBV data, obtained between 26 and 36 weeks of amenorrhea, contributed significantly, independently of hypertension, to the prediction of fetal outcome. With regard to maternal complications, no significant contribution of WBV data could be established independently of blood pressure. The results support the hypothesis that WBV is a determining factor in the efficacy of placental perfusion. © 1988 S. Karger AG, Basel.
Original languageEnglish
Pages (from-to)83-88
JournalGynecologic and obstetric investigation
Volume25
Issue number2
DOIs
Publication statusPublished - 1988
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Maternal whole blood viscosity in pregnancy hypertension'. Together they form a unique fingerprint.

Cite this